Abstract:We model investor heterogeneity using different required returns on an investment and evaluate the impact on the valuation of an investment. By assuming no disagreement on the cash flows, we emphasize how risk preferences in particular, but also the costs of capital, influence a subjective evaluation of the decision to invest now or retain the option to invest in future. We propose a risk-adjusted valuation model to facilitate investors' subjective decision making, in response to the market valuation of an investment opportunity. The investor's subjective assessment arises from their perceived misvaluation of the investment by the market, so projected cash flows are discounted using two different rates representing the investor's and the market's view. This liberates our model from perfect or imperfect hedging assumptions and instead, we are able to illustrate the hedging effect on the real option value when perceptions of risk premia diverge. During crises periods, delaying an investment becomes more valuable as the idiosyncratic risk of future cash flows increases, but the decision-maker may rush to invest too quickly when the risk level is exceptionally high. Our model verifies features established by classical real-option valuation models and provides many new insights about the importance of modelling divergences in decision-makers risk premia, especially during crisis periods. It also has many practical advantages because it requires no more parameter inputs than basic discounted cash flow approaches, such as the marketed asset disclaimer method, but the outputs are much richer. They allow for complex interactions between cost and revenue uncertainties as well as an easy exploration of the effects of hedgeable and un-hedgeable risks on the real option value. Furthermore, we provide fully-adjustable Python code in which all parameter values can be chosen by the user.

Incorporating Real Option Value in Valuing Innovation: A Way Forward

The Valuation of the Multistage Investment in an E&P Project Using a Four-Fold Compound Option

Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer

Application and Development of Real Option Theory and Method in Management of Technology and Innovation

Does Real Option Value Influence Oncologists' Treatment Recommendations? A Survey of US Oncologists

Valuation of Medical Innovation Handling with Uncertainty and Risk

Evaluating Technology Valuation Using Real Option Approach and Its Implications in Management

Risk-Adjusted Valuation for Real Option Decisions

Market valuation of international patenting using a real option approach: the moderating role of uncertainty

Ship Investment Valuation Using Real Option Analysis (ROA)

The Real Options Value Of Open Innovation Through Cross-Border Mergers And Acquisitions: Evidence From Publicly Listed Firms In China

A real-world way to manage real options

Strategic Options and Firm Value

Further Research on the Application of the Real Option to the Technological Exploitation Investment

Application of Real Options in Project Portfolio Selection

Multi-stage real option evaluation with double barrier under stochastic volatility and interest rate

Study on the Real Option in the Value Estimate of Coal Resources

Real Options in Operations Research: A Review

A Study on Timing of Design Innovation Investment Based on Real Options Theory

The use of options theory to value research in the service sector

Model Risk in Real Option Valuation